SOLICITATION NOTICE
66 -- MiSeq System Automated Generation of DNA Clonal Clusters
- Notice Date
- 1/27/2016
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 2016-Q-64674
- Point of Contact
- Shelley E. Kreimer, Phone: 7704882048
- E-Mail Address
-
xky4@cdc.gov
(xky4@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- THIS NOTICE IS FOR INFORMATIONAL PURPOSES ONLY. The Centers for Disease Control and Prevention (CDC), Center for Global Health contemplates award of a firm-fixed-price sole source purchase order to Illumina, Inc. at 5200 Illumina Way San Diego, CA 92122 for providing critical laboratory technology that possesses next generation DNA sequencing capabilities to assist with monitoring HIV drug resistance. This instrument will be used to meet the public health need of supporting surveillance of HIV drug resistance, specifically, in PEPFAE supported countries. With the scale-up of HIV antiretroviral therapy globally, countrywide HIVDR surveillance has to be conducted in order to monitor the effectiveness of HIV treatment programs. This instrument overcomes the bottleneck of the current technology by greatly increasing the capacity of sample size processing and HIVDR detection. Illumina, Inc. is the only vendor that is able to manufacture the reagents required for Miseq instruments. No other vendor produces similar or compatible reagents that can be used in the MiSeq instrument. This acquisition will use sole source simplified procedures in accordance with FAR 13.106(b)(1). This requirement is not set aside for small businesses. CDC is not requesting competitive proposals and no solicitation is available. Interested parties who believe they possess the capabilities to satisfy this requirement should indicate their interest in writing and submit a capability statement demonstrating their ability to meet this requirement no later than 5:00 PM Eastern Standard Time, on February 02, 2016. Determination not to compete this proposed action based on responses to this notice is solely within the discretion of the Government. Respondents will assume all financial costs for preparing a response to this notice. The U.S. Government assumes no financial obligation for the preparation and distribution of prepared responses. Inquiries may be sent to Shelley E. Kreimer, Esq. via email at xky4@cdc.gov
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2016-Q-64674/listing.html)
- Record
- SN04001855-W 20160129/160127233943-7921361ea4f7db7caa2d14e9fcf11875 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |